Research Ethics Board

William Osler Health System’s Research Ethics Board (REB) exists to ensure all research meets current scientific, regulatory, and ethical standards. All research involving patients, physicians, staff, students (i.e., research within the institution or using institutional resources), volunteers or visitors, must obtain ethical approval from the REB before research can begin. The REB has similar responsibility for investigators from other institutions who may wish to carry out research on Osler premises or with Osler patients. The REB reviews and approves research studies that meet acceptable ethical, regulatory and scientific standards and for which adequate facilities and resources are available. The REB also provides advice on the ethical, scientific and technical aspects of planning research projects. Heads of Departments / Divisions / Programs are responsible for ensuring that all such research is submitted for ethics review. 

The REB operates in compliance with the Tri Council Policy Statement 2 (TCPS2): Ethical Conduct for Research Involving Humans (2010), the International Conference on Harmonization (ICH) Good Clinical Practice (GCP) Guidelines, Part C Division 5 of the Food and Drug Regulations of Health Canada and the Personal Health Information Protection Act (PHIPA-Ontario 1998, updated through November 2005).

General Questions

In the event that an investigator cannot determine whether an intended investigation constitutes research (for instance, quality improvement studies do not constitute research), the investigator should contact the REB.

Ron Heslegrave, PhD
Corporate Chief of Research 
(905)494-2120 ext. 57767

Michelle Dimas, MSc
Research Ethics Board Coordinator 
(905)494-2120 ext. 50448

Related Information